Jetrea is a revolutionary medication that has been proven to effectively treat symptomatic vitreomacular adhesion (VMA). This condition occurs when the vitreous gel in the eye pulls away from the macula, causing distortion or loss of central vision. Jetrea works by dissolving the adhesion between the vitreous gel and the macula, allowing the macula to return to its normal position and improving vision.

Clinical trials have shown that Jetrea is a safe and effective treatment for VMA, with many patients experiencing significant improvement in their vision after just one injection. The medication is administered as a single injection into the vitreous cavity of the eye, and the procedure is typically performed in a doctor’s office or outpatient setting.

As with any medication, there are potential side effects associated with Jetrea. These may include temporary blurred vision, eye pain, and floaters. However, these side effects are usually mild and resolve on their own within a few days. It is important to discuss any concerns or questions about Jetrea with your healthcare provider before starting treatment.

Overall, Jetrea offers hope for patients suffering from symptomatic VMA by providing a non-invasive and effective treatment option. If you have been diagnosed with VMA and are experiencing vision problems, talk to your eye care provider about whether Jetrea may be a suitable treatment option for you. With proper care and monitoring, Jetrea can help improve your vision and quality of life.